|
WO2021076396A1
|
|
Monitoring of breathing and heart function
|
|
WO2021067668A1
|
|
Adamts13 treatment to enhance graft survival
|
|
WO2021067233A1
|
|
Bcl11a guide and base editor delivery
|
|
US2021077008A1
|
|
Systems and methods for analyzing concussion biomarkers
|
|
WO2021021503A1
|
|
Use of alveolar or airway organoids for the treatment of lung diseases and disorders
|
|
WO2020257401A1
|
|
Methods and compositions for the treatment of cancer
|
|
WO2020251887A1
|
|
Compositions and methods for the treatment of dba using gata1 gene therapy
|
|
WO2020198503A1
|
|
Therapeutic microbiota for the treatment and/or prevention of dysbiosis
|
|
WO2020185856A1
|
|
Methods for increasing platelet production
|
|
US2020171203A1
|
|
System and methods for connective tissue repair using scaffolds
|
|
WO2020154641A1
|
|
Methods and compositions for corrected aberrant splice sites
|
|
WO2020118036A1
|
|
Antibacterial compounds and uses thereof
|
|
WO2020117929A1
|
|
Methods and compositions for treating asthma
|
|
WO2020097437A1
|
|
Methods and compositions for treating or preventing the development of food allergies
|
|
WO2020092164A2
|
|
Methods and compositions for treating and preventing t cell-driven diseases
|
|
WO2020069180A1
|
|
Compositions and methods for cell transplantation
|
|
WO2020069187A1
|
|
Combination therapy for acute myeloid leukemia
|
|
CA3111436A1
|
|
Pneumococcal fusion protein vaccines
|
|
WO2020046882A1
|
|
Engineered semaphorins and uses thereof
|
|
WO2020023849A1
|
|
Compositions and methods for targeting a viral infection
|
